Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

IntroductionAnti-CD38-based therapy has become a backbone regimen for the treatment of multiple myeloma (MM), approved in first-, second-, and third-line settings. The effectiveness of anti-CD38-based retreatment after an initial relapse on previous anti-CD38-based therapy is unclear. Here we presen...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Francesca Gay, Elena Zamagni, Craig Emmitt Cole, Christof Scheid, Malin Hultcrantz, Justyna Chorazy, Ike Iheanacho, Anuja Pandey, Jacopo Bitetti, Natalie Boytsov, Molly Purser, Simon McNamara, Shinsuke Iida
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2025-03-01
Cyfres:Frontiers in Oncology
Pynciau:
anti-CD38
multiple myeloma
relapsed/refractory
systematic literature review
retreatment
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fonc.2025.1550644/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fonc.2025.1550644/full

Eitemau Tebyg